Skip to main content
Back to Equities

Advanced Enzyme

ADVENZYMES • Pharmaceuticals & Biotechnology

NSEEQ

Last Price

₹283.60

Market Cap

₹3.11K Cr

Sector

Pharmaceuticals & Biotechnology

For educational/research use only. Not a recommendation to buy or sell.

At a glance

as of 2026-11-13

Sector: Advanced Enzyme (ADVENZYMES) is an NSE-listed company in the Pharmaceuticals & Biotechnology sector, within the Biotechnology industry. NSE sector rotation chart

Sharia rating: Advanced Enzyme is rated Halal by a specialist third-party provider. Full list of halal NSE stocks

Halal▼ -0.18% today

28% below its 52-week high

Price trend

Strongly negative

Over the last 6 months, Advanced Enzyme's share price has fallen, doing better than 5% of Pharmaceuticals & Biotechnology stocks.

Institutional activity

Neutral

Trading patterns over recent weeks show no clear sign of institutions buying or selling Advanced Enzyme (buying score 1/10, selling score 0/10).

Model rank

Strongly positive

Our model's 5-day return score puts Advanced Enzyme ahead of 83% of NSE stocks. The model is only moderately confident (66%).

Ease of trading

Low

Shares change hands easily; there are no signs of trading drying up (risk score 2/10).

Price vs profits

Typical

The share price is 19× last year's profit per share — about in the typical range for NSE stocks (15–30×).

The wider Indian market is in a crisis regime — unusually sharp moves (model 100% sure). This affects every stock's model rank.

Browse ready-made screens →
Loading price data...

Company Information

NSE CodeADVENZYMES
ISININE837H01020
SeriesEQ
SectorPharmaceuticals & Biotechnology
IndustryBiotechnology

About Advanced Enzyme (ADVENZYMES)

Advanced Enzyme is an NSE-listed company operating in the Pharmaceuticals & Biotechnology sector, within the Biotechnology industry (ISIN INE837H01020). This page brings together the quantitative research signals our models compute for ADVENZYMES: a model-estimated 1-day, 5-day and 21-day return outlook, momentum and trend indicators, institutional-activity context derived from observed trading flows, a snapshot of valuation and quality fundamentals, and the instrument's Sharia-compliance status. All figures are produced by statistical models from historical data and are intended for research and educational purposes.

To read the page, treat the model-estimated return outlook as a relative ranking signal rather than a forecast of price — higher scores reflect stronger model-estimated momentum and trend alignment, not a target or guarantee. The momentum and trend indicators describe how Advanced Enzyme's recent price action compares with its own history, while the fundamentals and institutional-activity context add longer-horizon and flow-based perspective. Nothing here is investment advice, a recommendation, or a solicitation to transact; always do your own research and consult a SEBI-registered adviser before making any decision.

The "typical range" we compare a price-to-earnings multiple against is a fixed band for all NSE stocks, not a sector-specific one. Everything on this page describes what our models measured; none of it is a recommendation to do anything.